Nice. Thanks, Jukie!

TW has voluntarily dismissed (without prejudice so it can refile if necessary).

I'm attaching the TW voluntary dismissal. Apparently, the FDA felt that TW's marketing material contained some therapeutic claims, and TW, while certainly not agreeing with that assessment, nonetheless made changes requested by the FDA. There's no mention of what those changes were.

And with that, the docket watch is finally done.